Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31)
Neurotherapeutics - United States
doi 10.1007/s13311-019-00804-6
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Springer Science and Business Media LLC